The tumor immune microenvironment contributes to tumor initiation, progression, and response to therapy. Among the immune cell subsets that play a role in the tumor microenvironment, innate-like T cells that express T cell receptors composed of gamma and delta chains (gammadelta T cells) are of particular interest. gammadelta T cells can contribute to the immune response against many tumor types (lymphoma, myeloma, melanoma, breast, colon, lung, ovary, and prostate cancer) directly through their cytotoxic activity and indirectly by stimulating or regulating the biological functions of other cell types required for the initiation and establishment of the anti-tumor immune response, such as dendritic cells and cytotoxic CD8+ T cells. However, the notion that tumor-infiltrating gammadelta T cells are a good prognostic marker in cancer was recently challenged by studies showing that the presence of these cells in the tumor microenvironment was associated with poor prognosis in both breast and colon cancer. These findings suggest that gammadelta T cells may also display pro-tumor activities. Indeed, breast tumor-infiltrating gammadelta T cells could exert an immunosuppressive activity by negatively regulating dendritic cell maturation. Furthermore, recent studies demonstrated that signals from the microenvironment, particularly cytokines, can confer some plasticity to gammadelta T cells and promote their differentiation into gammadelta T cells with regulatory functions. This review focuses on the current knowledge on the functional plasticity of gammadelta T cells and its effect on their anti-tumor activities. It also discusses the putative mechanisms underlying gammadelta T cell expansion, differentiation, and recruitment in the tumor microenvironment.